This project aims to help older adults and people with neurological conditions such as stroke or Parkinson’s disease stay independent longer by developing a tablet-based digital therapeutic tool called SynapPlay. The platform combines physical and cognitive tasks with real-time feedback to improve balance, thinking skills, and motor control, all from the comfort of home. Through […]

Minerva Analytics Inc. is a technology startup focused on automating manual and repetitive processes in research laboratories. The goal is to free scientists from routine tasks so they can concentrate on complex analysis and innovation. Through AI-powered software tools, Minerva transforms traditional lab workflows—often reliant on manual data entry, disconnected spreadsheets, and inefficient communication—into streamlined, […]

Apical periodontitis is a disease caused by the persistence of microorganisms and their virulence factors in the root canal system. This infection leads to inflammation of the soft tissues and changes in the periapical bone structure. Bacteria such as Fusobacterium nucleatum and Parvimonas micra form biofilms that are resistant to conventional cleaning, making treatment more […]

Brain-Computer Interfaces (BCIs) are a revolutionary technology with the potential to significantly improve the lives of individuals with neurological disorders, but their long-term use is severely limited because the implants often fail within a short period. This project, a collaboration with Queen’s University, aims to solve this critical problem by developing and commercializing “Neuro-Integrated Carbene […]

In 2020, there were 19.3 million new cancer cases and 9.9 million related deaths, with 70% occurring in low- and middle-income countries. In Latin America, cancer remains a leading cause of mortality, with cases projected to rise from 4 million in 2020 to 6 million by 2040. Indigenous populations are among the most affected; in […]

Many people with heart failure are not prescribed the full set of guideline-directed medical therapies (GDMT), which can shorten their lifespan and reduce quality of life. One major reason is the difficulty and inconvenience of regularly checking potassium and creatinine levels, which are needed to safely adjust these medications. To address this, we are developing […]

Our academic lab has developed technology that could have potential benefits in the Canadian healthcare system. This technology is highly specialized that combines MRI and interventional cardiac treatment. The intern will determine if our technology can satisfy the needs dictated by various stakeholders in the industry, such that a startup is warranted. This objective will […]

The mission of PI16 Therapeutics is to improve skin health for the ~4 million Canadian’s suffering from long-term skin diseases, including clinically dry skin, chronic wounds, and severe burns. PI16 Therapeutics aims to produce skin solutions for these individuals by genetically engineering naturally occurring stem-cell like fibroblasts that express the gene Peptidase Inhibitor 16 (Pi16) […]

U-Pro Soccer is a Canadian sportstech company developing a mobile-first training platform that uses AI and computer vision to help youth athletes practice soccer drills at home using only a smartphone and a training mat. Many young players lack access to structured training, especially outside of team environments, and U-Pro aims to fill this gap […]

Le projet de recherche examinera dans quelle mesure le système actuel de pharmacovigilance au Canada s’aligne sur les normes mondiales tout en répondant aux défis réglementaires locaux. La pharmacovigilance assure la sécurité des médicaments en surveillant et en gérant les risques potentiels. Bien que le Canada suive les lignes directrices internationales, il dispose également de […]

Les substances per- et polyfluoroalkylées (PFAS) sont des produits chimiques utilisés pour leurs propriétés résistantes à l’eau et à l’huile, mais elles sont aussi très persistantes dans l’environnement et peuvent nuire à la santé humaine. Ce projet vise à étudier la présence des PFAS dans les produits pharmaceutiques, un domaine encore peu exploré. En collaboration […]

Les chondrosarcomes extra-squelettiques sont des tumeurs rares dont le traitement repose principalement sur la chirurgie. Toutefois, l’ajout d’une radiothérapie avant l’opération (radiothérapie néo-adjuvante) pourrait aider à réduire la taille de la tumeur et faciliter son retrait. Ce projet de recherche vise à mieux comprendre les bénéfices et les risques de cette approche en comparant des […]